ANTIDIABETICS Side Effects

5394371-X | Hypertension, International Normalised Ratio Decreased, Thrombosis
on Jul 17, 2007 Male patient from BRAZIL , 71 years of age, weighting 176.4 lb, was diagnosed with hypertension and was treated with Antidiabetics (View Usage). Patient experienced the following unwanted or unexpected effects: hypertension, international normalised ratio decreased, thrombosis. Antidiabetics dosage: . During the same period patient was treated with ANTIARRHYTHMICS, CLASS I AND III (View Antiarrhythmics, Class I And Iii Review and Antiarrhythmics, Class I And Iii Label ), DIOVAN (80 Mg/day) (View Diovan Review and Diovan Label ).

5141107-3 | Hypertension, Thrombosis
Patient was taking Antidiabetics (View Usage). Patient had the following side effects: hypertension, thrombosis on Oct 19, 2006 from BRAZIL Additional patient health information: Male patient , 71 years of age, weighting 176.4 lb, was diagnosed with hypertension and. Antidiabetics dosage: . During the same period patient was treated with ANTIARRHYTHMICS, CLASS I AND III (View Antiarrhythmics, Class I And Iii Review and Antiarrhythmics, Class I And Iii Label ), DIOVAN (80 Mg/day) (View Diovan Review and Diovan Label ).

5127070-X | Diabetic Neuropathy, Iiird Nerve Paralysis
Adverse event was reported on Sep 20, 2006 by a Male patient taking Antidiabetics (View Usage) (Dosage: ) was diagnosed with chronic myeloid leukaemia and. Location: AUSTRALIA , 41 years of age, After Antidiabetics was administered, patient had the following side effects: diabetic neuropathy, iiird nerve paralysis. During the same period patient was treated with GLEEVEC (400mg) (View Gleevec Review and Gleevec Label ).

5126951-0 | Csf Protein Increased, Diabetic Neuropathy, Hyperglycaemia, Iiird Nerve Paralysis
on Sep 20, 2006 Male patient from AUSTRALIA , 41 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Antidiabetics (View Usage). Patient experienced the following unwanted or unexpected effects: csf protein increased, diabetic neuropathy, hyperglycaemia, iiird nerve paralysis. Antidiabetics dosage: . During the same period patient was treated with GLEEVEC (400mg) (View Gleevec Review and Gleevec Label ).


5120889-0 | Diabetic Neuropathy, Iiird Nerve Paralysis
on Sep 20, 2006 Male patient from AUSTRALIA , 41 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Antidiabetics (View Usage). Patient had the following side effects: diabetic neuropathy, iiird nerve paralysis. Antidiabetics dosage: . During the same period patient was treated with GLEEVEC (400mg) (View Gleevec Review and Gleevec Label ).

4617587-6 | Disease Progression, Dyspnoea, Emphysema, Laryngeal Stenosis, Pneumonia, Tracheostomy
Patient was taking Antidiabetics (View Usage). After Antidiabetics was administered, patient had the following side effects: disease progression, dyspnoea, emphysema, laryngeal stenosis, pneumonia (What is pneumonia?), tracheostomy on Oct 18, 2004 from Additional patient health information: Male patient , 73 years of age, weighting 198.4 lb, was diagnosed with emphysema and. Antidiabetics dosage: . During the same period patient was treated with ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ), ANTIGOUT PREPARATIONS (View Antigout Preparations Review and Antigout Preparations Label ), FORASEQ (Unk, Bid) (View Foraseq Review and Foraseq Label ). Patient was hospitalized.